Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,744 total, page 30 of 35
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
NCT00767936
Promoting Healthy Weight With 'Stability Skills First'
NCT00626457
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
NCT00661154
A Study of N-Acetyl Cysteine in Children With Autism
NCT00627705
Study of Pain Processing in Subjects Suffering From Obstructive Sleep Apnea
NCT00672737
Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies
NCT00977639
Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT
NCT00725946
Effectiveness of Cognitive Remediation Therapy in Improving Treatment Retention in People With Anorexia Nervosa
NCT00601822
Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
NCT00481845
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
NCT00610415
Subcutaneous Botulinum Toxin for Cutaneous Allodynia
NCT00725322
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
NCT00854620
RAL-eve Study: Raltegravir Substitution Study
NCT00523237
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
NCT00537056
Effects of a Peripheral Nerve Block on Biomarkers of Pain and Inflammation
NCT00780936
Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)
NCT01827462
Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women
NCT00541931
Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder
NCT00601354
Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy
NCT00725387
Feasibility Study of Exercises for Myeloablative Allogeneic Blood and Marrow Transplantation (BMT) Patients
NCT01396031
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
NCT00572117
Postoperative Pain and Functional Patient Outcomes After Functional Endoscopic Sinus Surgery
NCT00927888
Genomic Analysis of Pediatric Bone Tumors
NCT01047878
Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer
NCT00490334
Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast
NCT00473005
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
NCT00568633
Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
NCT00533572
Imatinib in Systemic Sclerosis
NCT00506831
Pharmacokinetics of Ketamine in Infants and Children
NCT00553839
Insulin Resistance in Patients With Mood Disorder
NCT00242619
Effects of Low Dose Naltrexone in Fibromyalgia
NCT00568555
Ethnic Dance and Screen Time Reduction to Prevent Weight Gain in Latina Girls
NCT00476775
Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
NCT00478465
Development of Algorithms for a Hypoglycemic Prevention Alarm: Closed Loop Study
NCT00884611
English Diabetes Self-Management Program
NCT00684086
Healing Touch During Chemotherapy Infusions for Women With Breast Cancer
NCT00533663
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050
Indomethacin Versus Nifedipine for Preterm Labor Tocolysis
NCT00486824
Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review
NCT01515631
Immunobiology of Diabetes and Tuberculosis
NCT00568854
Nutrition Intervention and Play Group Exercise for Low-income Latinas
NCT00454948
Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
NCT00466713
Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome
NCT01254045
Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
NCT00568282
Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure
NCT01023178
Geodon in Weight Loss Study for Bipolar Disorders
NCT00472641
Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus
NCT00449891
One Hour Preoperative Gatifloxacin
NCT00350363
Day of Embryo Transfer for Patients Undergoing In Vitro Fertilization
NCT00615771
Caffeine/Propranolol Intervention for Acute Migraine
NCT01080677
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.